Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Prof Jonathan Jansen’s term extended for a further five years
2014-03-19

During its first meeting of the year, held on Friday 14 March 2014 on the Bloemfontein Campus, the Council of the University of the Free State (UFS) decided to appoint Prof Jonathan Jansen for a further term as Vice-Chancellor and Rector.

Prof Jansen was appointed in this position on 1 July 2009. His term will be extended for a further five years on 1 July 2014.

“Prof Jansen’s vision for the future of the UFS is in line with that of Council. He led the university successfully through a challenging time and his ability to bring people from different backgrounds together has made a huge difference in how the institution is perceived nationally and internationally. We are thankful that his services could be maintained for a further term and look forward to working with him,” said Judge Ian van der Merwe, Chairperson of the Council.

Prof Jansen said that he is honoured and humbled to be granted a second term. “I will work even harder to advance academic excellence and deepen human relations at this great institution," he said.

The term of the Vice-Chairperson of the Council, Mr Edward Kieswetter, was also extended for another three years during the meeting. Mr Kieswetter, Group Chief Executive of Alexander Forbes Equity Holdings (Pty) Ltd, has been a member of the Council since November 2004. This will be his third term as Vice-Chairperson.

Issued by: Lacea Loader (Director: Communication and Brand Management)
Telephone: +27(0)51 401 2584 or +27 (0) 83 645 2454
E-mail: news@ufs.ac.za
Fax: +27 (0) 51 444 6393

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept